Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-07 9:54 pm Purchase |
2025-04-03 | 13D | Harrow Health, Inc. HROW |
BAUM MARK L | 4,056,962 10.690% |
568,601 (+16.30%) |
Filing History |
| 2024-12-05 7:08 pm Sale |
2024-08-12 | 13G | Harrow Health, Inc. HROW |
Daniel Kaufman | 1,684,424 4.750% |
-222,908 (-11.69%) |
Filing History |
| 2024-10-08 06:41 am Sale |
2022-12-31 | 13G | Harrow Health, Inc. HROW |
Ophir Asset Management Pty Ltd | 768,916 2.800% |
-1,136,438 (-59.64%) |
Filing History |
| 2024-04-30 07:00 am Sale |
2024-04-26 | 13D | Eton Pharmaceuticals, Inc. ETON |
HARROW INC. HROW |
0 0.000% |
-1,982,000 (Position Closed) |
Filing History |
| 2024-02-13 5:25 pm Purchase |
2023-12-31 | 13G | Harrow Health, Inc. HROW |
Daniel Kaufman | 1,907,332 5.430% |
22,300 (+1.18%) |
Filing History |
| 2024-02-13 5:06 pm Purchase |
2023-12-29 | 13G | Harrow Health, Inc. HROW |
The Vanguard Group | 1,808,552 5.150% |
1,808,552 (New Position) |
Filing History |
| 2024-02-09 4:05 pm Purchase |
2023-12-31 | 13G | Harrow Health, Inc. HROW |
Opaleye Management Inc. | 3,820,000 10.880% |
45,000 (+1.19%) |
Filing History |
| 2024-01-29 3:26 pm Purchase |
2023-12-31 | 13G | Harrow Health, Inc. HROW |
BLACKROCK INC BLK |
2,220,538 6.300% |
1,806,673 (+436.54%) |
Filing History |
| 2024-01-09 10:16 am Purchase |
2023-12-31 | 13G | Harrow Health, Inc. HROW |
Private Capital Management, LLC | 3,630,496 10.340% |
3,630,496 (New Position) |
Filing History |
| 2023-11-22 7:23 pm Purchase |
2023-11-15 | 13G | Harrow Health, Inc. HROW |
Daniel Kaufman | 1,885,032 5.370% |
1,885,032 (New Position) |
Filing History |
| 2023-08-18 4:42 pm Purchase |
2023-07-18 | 13D | Harrow Health, Inc. HROW |
BAUM MARK L | 3,488,361 9.500% |
3,488,361 (New Position) |
Filing History |
| 2023-01-20 4:59 pm Purchase |
2022-12-31 | 13G | Harrow Health, Inc. HROW |
Opaleye Management Inc. | 3,775,000 12.820% |
490,000 (+14.92%) |
Filing History |
| 2022-02-14 3:22 pm Purchase |
2021-12-31 | 13G | Harrow Health, Inc. HROW |
Ophir Asset Management Pty Ltd | 1,905,354 7.080% |
1,905,354 (New Position) |
Filing History |
| 2022-02-10 4:32 pm Sale |
2021-12-31 | 13G | Harrow Health, Inc. HROW |
Renaissance Technologies LLC | 1,199,112 4.460% |
-294,100 (-19.70%) |
Filing History |
| 2022-01-28 4:05 pm Sale |
2021-04-12 | 13D | Eton Pharmaceuticals, Inc. ETON |
HARROW INC. HROW |
1,982,000 8.100% |
-1,518,000 (-43.37%) |
Filing History |
| 2022-01-25 9:43 pm Purchase |
2021-12-31 | 13G | Harrow Health, Inc. HROW |
Opaleye Management Inc. | 3,285,000 12.200% |
219,584 (+7.16%) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Harrow Health, Inc. HROW |
BLACKROCK INC BLK |
413,865 1.600% |
-1,118,799 (-73.00%) |
Filing History |
| 2021-04-27 5:25 pm Purchase |
2021-04-25 | 13D | IMPRIMIS PHARMACEUTICALS, INC. IMMY |
BAUM MARK L | 2,367,072 8.600% |
897,662 (+61.09%) |
Filing History |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | Harrow Health, Inc. HROW |
Opaleye Management Inc. | 3,065,416 11.910% |
3,065,416 (New Position) |
Filing History |
| 2021-02-10 11:01 am Purchase |
2020-02-27 | 13G | Harrow Health, Inc. HROW |
Renaissance Technologies LLC | 1,493,212 5.800% |
1,493,212 (New Position) |
Filing History |